TL;DR: On April 22, 2026, the DOJ rescheduled medical cannabis from Schedule I to Schedule III, ending Section 280E tax penalties for state-licensed medical operators. Medical cannabis businesses move from 70% effective tax rates to normal 21-28% rates. Adult-use operators still face the same penalties until broader rescheduling occurs.
Medical cannabis operators paid 70% to 80% effective federal tax rates while competitors in every other industry paid 21% to 28%. The gap had nothing to do with performance. Section 280E of the Internal Revenue Code created this penalty by prohibiting cannabis businesses from deducting ordinary business expenses.
For decades, these operators deducted only Cost of Goods Sold while rent, payroll, utilities, marketing, interest, depreciation, and administrative costs stayed non-deductible. The restriction applied because cannabis sat in Schedule I of the Controlled Substances Act alongside heroin.
The April 22, 2026 Department of Justice order rescheduled state-licensed medical cannabis to Schedule III. Section 280E no longer applies to medical operations. This removes a Reagan-era drug war mechanism that extracted an estimated $15 billion from cannabis businesses since 2018.
Relief arrives immediately for medical operators. Adult-use businesses stay subject to the same structure that has compressed margins since state legalization began.
What Section 280E Does to a Business
Section 280E prohibits cannabis businesses from deducting ordinary and necessary business expenses. Rent, payroll, utilities, marketing, interest, depreciation, administrative costs get disallowed. The only deduction permitted is Cost of Goods Sold.
Picture running a restaurant where you deduct the food but not the rent, staff wages, or utilities. You get taxed on revenue as if those expenses never existed. State-licensed cannabis businesses operated this way while the federal government classified their product as Schedule I.
A dispensary with $5 million in revenue, $2 million in COGS, and $2 million in operating expenses pays an effective federal tax rate of roughly 70% under Section 280E. A non-cannabis business with identical financials pays roughly 21%. The U.S. Senate Finance Committee documented cases where operators faced effective rates as high as 80%.
Section 280E was created intentionally in 1982 after a convicted cocaine trafficker successfully claimed business expense deductions in court. Congress wanted to prevent drug dealers from benefiting from tax deductions. The mechanism punishes state-legal businesses far more severely than the illegal operations Congress designed it to target.
Bottom line: Section 280E turned profitable cannabis businesses into tax-loss operations by disallowing 50% to 65% of total business expenses.
Why Retail Dispensaries Suffered Most
The tax code’s focus on Cost of Goods Sold created a structural disadvantage for retail operators compared to cultivators and manufacturers.
Retail dispensaries faced the most punitive impact because their primary activity is selling, not producing. Dispensaries typically classify only 35% to 50% of total expenses as COGS. Cultivators classify 65% to 75% of expenses as COGS because production activities qualify. Higher COGS classification translates to lower effective tax rates under 280E.
For a dispensary operating on 45% to 55% product margins, Section 280E effectively taxes the entire gross margin plus all operating expenses. This produces effective tax rates that routinely exceed 70%. This explains why retail operators struggled with profitability despite strong revenue growth in expanding state markets.
Dispensaries carry higher labor costs, higher real estate expenses in premium retail locations, and significant marketing and compliance costs that cultivators do not face. All of those expenses became non-deductible under 280E, compressing margins to levels that would be unsustainable in any other retail category.
Key insight: Retail operators faced 70%+ effective tax rates while cultivators faced 40-50% rates due to COGS classification differences.
What Changed on April 22, 2026
The DOJ order creates an immediate split in the cannabis tax landscape. Medical cannabis subject to a state license is no longer subject to Section 280E. Medical operators deduct standard business expenses under IRC Section 162, the same provision every other business uses.
The order also encourages the Treasury Department to consider retrospective relief for state-licensed medical marijuana companies for prior taxable years. This opens the possibility of refunds or credits for taxes paid under 280E in previous years. The mechanism and eligibility criteria for retrospective relief are not finalized yet.
Adult-use operators receive no direct relief from this order. Cannabis outside of FDA-approved and state-licensed medical systems remains a Schedule I controlled substance. Section 280E continues to apply. A DEA administrative hearing beginning June 29, 2026 will consider broader rescheduling of all marijuana from Schedule I to Schedule III. Until that process concludes, adult-use operators remain subject to the 1982 tax penalty.
This creates a bifurcated market where medical and adult-use operators in the same state face dramatically different tax treatment. Operators with dual licenses need to carefully segregate revenue and expenses between the two sides of their business to maximize the benefit of 280E relief on the medical side while maintaining compliance on the adult-use side.
What this means: Medical operators move to 21-28% effective tax rates immediately. Adult-use operators stay at 70%+ rates until DEA rescheduling concludes.
The Economic Impact
The removal of Section 280E for medical operators unlocks capital trapped in tax payments for years. Projections from Vicente LLP suggest that full rescheduling and 280E reform across the entire cannabis industry would result in the creation of 55,000 jobs by 2030, generating as much as $2.7 billion in wages and $5.6 billion in new economic activity.
Those projections were based on industry-wide relief. The current order covers only medical operations, which represent a smaller portion of the total market in most states. The economic impact will concentrate in states with robust medical programs and operators who maintained separate medical licenses even as adult-use markets expanded.
The immediate effect for medical operators is increased after-tax cash flow. Businesses operating on razor-thin margins or at a loss due to 280E will see profitability improve. This creates opportunities for reinvestment in facilities, technology, compliance infrastructure, and expansion into new markets.
The longer-term effect depends on how the industry responds to the bifurcated tax structure. Medical operators gain a competitive advantage over adult-use operators in states where both programs exist. This could drive more operators to maintain or reactivate medical licenses, which expands patient access but also creates additional regulatory complexity.
The pattern emerging: Medical operators gain 40-50 percentage point tax advantage over adult-use competitors in dual-license states.
How to Adjust Your Tax Strategy
State-licensed medical cannabis businesses need to update tax planning immediately. The deductions unavailable for years are now accessible. Rent, payroll, utilities, marketing, interest, depreciation, administrative costs become deductible business expenses under IRC Section 162.
This changes your effective tax rate, your cash flow projections, and your ability to reinvest in your business. This also changes the conversation you need with your CPA. If your tax advisor has not yet discussed how to restructure your expense classification and maximize newly available deductions, you are working with someone who has not kept pace with the regulatory changes affecting your industry.
Adult-use operators receive no relief from the current order, but the order signals the direction of federal policy. The DEA hearing scheduled for June 29, 2026 represents the next opportunity for broader rescheduling that would extend 280E relief to the entire cannabis industry. Preparing now means understanding how your expense structure would change under normal tax treatment and what that means for your margins and reinvestment capacity.
Operators with both medical and adult-use licenses face an immediate priority: segregation. You need clean separation between medical and adult-use revenue and expenses to maximize the benefit of 280E relief on the medical side while maintaining compliance on the adult-use side. The IRS will expect clear documentation supporting the allocation of expenses between the two sides of your business.
Action step: Medical operators should revise expense classification, update cash flow models, and file amended returns if retrospective relief becomes available.
What I’m Watching Now
I have spent years helping businesses identify tax strategies that the wealthy have always used but that most operators assume are not available to them. The cannabis industry has been operating under a tax penalty so severe that it would have eliminated most other industries entirely. The fact that cannabis businesses survived and grew under 280E demonstrates resilience, but it also demonstrates how much capital has been extracted unnecessarily.
The removal of Section 280E for medical operators is the first significant federal policy shift that acknowledges the disconnect between state-legal cannabis businesses and the drug dealers the tax code was designed to target in 1982. The DEA hearing in June will determine whether adult-use operators receive the same relief.
What I am watching now is how quickly medical operators adapt their tax strategies to take advantage of newly available deductions, and how the bifurcated tax structure affects competitive dynamics in states with both medical and adult-use programs. The operators who move quickly and work with advisors who understand the regulatory landscape will gain an advantage. The operators who wait or who assume their current CPA is handling the transition will leave money on the table.
Tax strategy is not a luxury reserved for the ultra-wealthy. Tax strategy is a structural advantage available to anyone willing to learn how the rules work and how to apply them. The cannabis industry received access to deductions that every other industry has taken for granted for decades. The question now is who moves first and who waits to see what happens.
Frequently Asked Questions
Does the April 2026 DOJ order eliminate Section 280E for all cannabis businesses?
No. The order eliminates Section 280E only for state-licensed medical cannabis operators. Adult-use cannabis businesses still face Section 280E restrictions until broader DEA rescheduling occurs.
What is Section 280E and why does it matter?
Section 280E prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses. Only Cost of Goods Sold remains deductible. This creates effective tax rates of 70% to 80% for cannabis businesses compared to 21% to 28% for other industries.
When will adult-use cannabis operators get Section 280E relief?
A DEA administrative hearing beginning June 29, 2026 will consider rescheduling all marijuana from Schedule I to Schedule III. If approved, adult-use operators would gain the same Section 280E relief that medical operators received in April 2026.
Will medical cannabis operators get refunds for taxes paid under Section 280E in prior years?
The April 2026 DOJ order encourages the Treasury Department to consider retrospective relief for prior taxable years. The mechanism and eligibility criteria have not been finalized. Medical operators should monitor Treasury guidance on amended return procedures.
How should dual-license operators handle the split between medical and adult-use operations?
Operators with both medical and adult-use licenses must segregate revenue and expenses between the two sides of the business. Medical revenue and expenses qualify for normal IRC Section 162 deductions. Adult-use revenue and expenses remain subject to Section 280E restrictions. The IRS will require clear documentation supporting expense allocation.
What business expenses become deductible for medical cannabis operators after April 2026?
Medical operators deduct rent, payroll, utilities, marketing, interest, depreciation, insurance, professional fees, and administrative costs under IRC Section 162. These expenses were previously non-deductible under Section 280E.
Why did retail dispensaries face higher effective tax rates than cultivators under Section 280E?
Dispensaries classify only 35% to 50% of total expenses as Cost of Goods Sold because their primary activity is selling. Cultivators classify 65% to 75% of expenses as COGS because production activities qualify. Higher COGS classification produces lower effective tax rates under Section 280E.
How much has Section 280E cost the cannabis industry?
Section 280E extracted an estimated $15 billion from cannabis businesses between 2018 and 2026. Full rescheduling and 280E reform across the industry could create 55,000 jobs by 2030 and generate $5.6 billion in new economic activity.
Key Takeaways
-
Medical cannabis operators gained immediate Section 280E relief on April 22, 2026 when the DOJ rescheduled medical cannabis from Schedule I to Schedule III.
-
Medical operators move from 70-80% effective tax rates to normal 21-28% rates by deducting ordinary business expenses under IRC Section 162.
-
Adult-use cannabis businesses remain subject to Section 280E until broader DEA rescheduling concludes after the June 29, 2026 hearing.
-
Dual-license operators must segregate medical and adult-use revenue and expenses to maximize tax benefits while maintaining IRS compliance.
-
Retail dispensaries faced higher Section 280E penalties than cultivators because only 35-50% of dispensary expenses qualified as COGS compared to 65-75% for cultivators.
-
Section 280E extracted $15 billion from cannabis businesses between 2018 and 2026. Full industry relief could create 55,000 jobs and $5.6 billion in economic activity by 2030.
-
Medical operators should immediately revise expense classification, update cash flow projections, and prepare for potential retrospective relief through amended returns.
For more information on this and other tax strategies, follow The Tax Strategy Playbook Podcast, available on YouTube and all major podcast platforms.
Leave a Reply